APA (7th ed.) Citation

B, V. D. B., SS, B., N, M., S, N. A., R, G., J, G., . . . TF, R. (2026). Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomised, double-blinded, multicentre, phase 2 study. The European respiratory journal, 68(1), . https://doi.org/10.1183/13993003.01874-2025

Chicago Style (17th ed.) Citation

B, Van Den Blink, et al. "Safety and Efficacy of Namilumab for the Treatment of Chronic Pulmonary Sarcoidosis (RESOLVE-Lung): A Randomised, Double-blinded, Multicentre, Phase 2 Study." The European Respiratory Journal 68, no. 1 (2026). https://doi.org/10.1183/13993003.01874-2025.

MLA (9th ed.) Citation

B, Van Den Blink, et al. "Safety and Efficacy of Namilumab for the Treatment of Chronic Pulmonary Sarcoidosis (RESOLVE-Lung): A Randomised, Double-blinded, Multicentre, Phase 2 Study." The European Respiratory Journal, vol. 68, no. 1, 2026, https://doi.org/10.1183/13993003.01874-2025.